Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase [PDF]
H. James Harwood+10 more
openalex +1 more source
Objectives. This study aims to evaluate the effectiveness of initial insulin therapy versus oral hypoglycemic agents in glucose control among newly diagnosed Type 2 diabetes patients. Methodology.
Ma. Marylaine Dujunco+3 more
doaj
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes [PDF]
Cristina Bianchi+4 more
openalex +1 more source
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No [PDF]
Sameer Kassem, Itamar Raz
openalex +1 more source
Selection of the optimal hypoglycemic agent for type 2 diabetes: based on the 2009 consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes [PDF]
Gwanpyo Koh
openalex +1 more source
Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
Stephen J. Boccuzzi+5 more
openalex +1 more source
Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin [PDF]
Takuo Nambu+6 more
openalex +1 more source